Tomas Stopka

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Redox-dependent protein S-glutathionylation governs azacitidine sensitivity and resistance in AML.

Redox-dependent protein S-glutathionylation governs azacitidine sensitivity and resistance in AML.

Journal: Redox biology

Published: October 21, 2025

Rps19 R67∆ mutation creates a model of Diamond-Blackfan anemia and reveals downstream mediators of p53 pathway.

Rps19 R67∆ mutation creates a model of Diamond-Blackfan anemia and reveals downstream mediators of p53 pathway.

Journal: HemaSphere

Published: August 11, 2025

Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.

Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 10, 2025

Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing.

Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing.

Journal: Immunity

Published: February 10, 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML.

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML.

Journal: Frontiers in oncology

Published: April 09, 2024

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa.

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa.

Journal: Frontiers in oncology

Published: March 09, 2024

SMARCA5-mediated chromatin remodeling is required for germinal center formation.

SMARCA5-mediated chromatin remodeling is required for germinal center formation.

Journal: The Journal of experimental medicine

Published: March 08, 2024

Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG/TP53INP1/CDKN1A/CCND1 network.

Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG/TP53INP1/CDKN1A/CCND1 network.

Journal: Archives of medical research

Published: January 04, 2024

Differential requirements for Smarca5 expression during hematopoietic stem cell commitment.

Differential requirements for Smarca5 expression during hematopoietic stem cell commitment.

Journal: Communications biology

Published: May 29, 2023

Chromatin remodeling enzyme Snf2h is essential for retinal cell proliferation and photoreceptor maintenance.

Chromatin remodeling enzyme Snf2h is essential for retinal cell proliferation and photoreceptor maintenance.

Journal: bioRxiv : the preprint server for biology

Published: February 24, 2023

Chromatin Remodeling Enzyme Snf2h Is Essential for Retinal Cell Proliferation and Photoreceptor Maintenance.

Chromatin Remodeling Enzyme Snf2h Is Essential for Retinal Cell Proliferation and Photoreceptor Maintenance.

Journal: Cells

Published: February 14, 2023

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.

Journal: Blood cancer journal

Published: April 14, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026